Skip to main content
HT

HaiF Tech

HAIF develops software utilizing artificial intelligence to predict the risk of heart failure within the next six months by analyzing simple ECG data. This predictive capability allows for earlier intervention and treatment initiation for at-risk patients. The solution offers a fast and cost-effective method for heart failure risk assessment compared to existing diagnostic standards.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Heart failure often goes undetected until it reaches an advanced stage, leading to increased mortality rates and high healthcare costs. Traditional diagnostic methods can be expensive, time-consuming, and may not always provide early or accurate predictions of heart failure risk. This results in delayed interventions and poorer patient outcomes.

Solution

HAIF offers a patented, AI-powered solution that analyzes standard 12-lead ECG data to predict the risk and detect the presence of heart failure. The algorithm characterizes the heart’s mechanical function, enabling early, non-invasive screening without the need for additional expensive diagnostic tests. By identifying at-risk individuals months before symptoms manifest, HAIF facilitates timely interventions and improved patient management. The technology seamlessly integrates with existing ECG and cardiac monitoring systems, providing real-time assessments and cost-effective screening.

Target Audience

The primary target audience includes hospitals, diagnostic centers, ECG device manufacturers, and ECG software providers seeking to improve heart failure detection and patient care.

Features

  • AI-powered algorithm analyzes standard 12-lead ECGs
  • Predicts heart failure risk months before symptoms appear
  • Provides risk assessments for blood potassium and glucose levels from ECG data
  • Coronary ischemia screening to assess patient's risk of heart attack
  • Seamless integration with existing ECG and cardiac monitoring systems
  • Non-invasive and cost-effective screening solution
  • Cloud-based platform for data analysis and reporting
  • Mobile and web dashboards for clinicians and administrators
This profile is AI-generated and may contain inaccuracies.